Resources

The Canadian government has decided to add bisphenol A to the country’s list of toxic substances, a move that is likely to renew attention on the widespread use of the controversial chemical linked to diabetes, liver and heart disease.

Immunotherapy against a major autoantigen in type 1 diabetes may preserve beta-cell function early after disease onset but not reverse the process, researchers said.

Combination therapy with GLP-1 and gastrin restores normoglycemia.

After 10 year follow-up of those Type 2 patients in the UKPDS who received intensive glucose therapy, they found less microvascular complications.

Weight gain in early life predicts risk of islet autoimmunity in children with a first degree relative with type 1 diabetes.

Strengthening patients’ self-efficacy may improve the control of HbA1c and may result in a decrease of ethnic differences in outcomes.

Prozac (fluoxetine), can amplify ANS and metabolic counterregulatory mechanisms during moderate hypoglycemia in patients with type 1 diabetes.

The US Department of Health and Human Services (HHS) has issued guidelines regarding the types and amounts of physical activity that provide substantial health benefits for physical activity for individuals 6 years and older.

Scientists at Edinburgh University yesterday revealed they have moved a step closer to a cure for diabetes, thanks to groundbreaking stem-cell research.

Researchers have identified a particular subset of cells that are linked to obesity-associated insulin resistance, and that offer a promising new target for the treatment of diabetes.